Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Edwards Lifesciences Corp (EW) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Edwards Lifesciences Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1099800.
Total stock buying since 2015: $2,320,964.
Total stock sales since 2015: $955,812,098.
Total stock option exercises since 2015: $269,667,795.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 147,070 | $10,880,959 | 121,833 | $5,766,927 |
| 2024 | 580 | $49,730 | 436,617 | $36,821,216 | 443,141 | $15,365,052 |
| 2023 | 0 | $0 | 776,089 | $62,525,471 | 866,651 | $31,038,662 |
| 2022 | 0 | $0 | 722,684 | $73,906,699 | 972,597 | $23,063,224 |
| 2021 | 1,500 | $168,345 | 1,052,239 | $103,810,080 | 1,416,122 | $24,477,104 |
| 2020 | 0 | $0 | 1,262,598 | $128,977,831 | 1,566,127 | $30,035,920 |
| 2019 | 0 | $0 | 659,193 | $130,721,340 | 729,376 | $27,492,262 |
| 2018 | 0 | $0 | 888,652 | $124,048,601 | 871,925 | $32,595,505 |
| 2017 | 3,000 | $270,300 | 874,538 | $93,390,028 | 973,747 | $31,725,623 |
| 2016 | 20,870 | $1,832,589 | 1,079,098 | $105,613,525 | 1,213,936 | $28,166,951 |
| 2015 | 0 | $0 | 629,600 | $85,116,348 | 638,465 | $19,940,565 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 11,450 | $903,546 | 8,950 | $530,350 |
| 2025-07 | 0 | $0 | 4,114 | $326,902 | 0 | $0 |
| 2025-06 | 0 | $0 | 12,487 | $946,953 | 8,950 | $530,350 |
| 2025-05 | 0 | $0 | 35,427 | $2,685,371 | 19,042 | $862,163 |
| 2025-04 | 0 | $0 | 9,800 | $684,378 | 9,800 | $443,714 |
| 2025-03 | 0 | $0 | 27,314 | $1,899,123 | 28,613 | $1,295,509 |
| 2025-02 | 0 | $0 | 40,978 | $3,056,569 | 40,978 | $1,855,818 |
| 2025-01 | 0 | $0 | 5,500 | $378,117 | 5,500 | $249,023 |
| 2024-12 | 0 | $0 | 4,833 | $356,133 | 2,500 | $113,192 |
| 2024-11 | 0 | $0 | 30,000 | $1,975,720 | 5,000 | $226,385 |
| 2024-10 | 0 | $0 | 5,000 | $347,535 | 5,000 | $226,385 |
| 2024-09 | 0 | $0 | 5,000 | $333,825 | 5,000 | $226,385 |
| 2024-08 | 0 | $0 | 6,250 | $417,857 | 5,000 | $226,385 |
| 2024-07 | 0 | $0 | 5,500 | $513,565 | 5,500 | $249,023 |
| 2024-06 | 0 | $0 | 11,160 | $979,663 | 11,160 | $505,291 |
| 2024-05 | 580 | $49,730 | 65,563 | $5,628,837 | 97,872 | $2,183,362 |
| 2024-04 | 0 | $0 | 71,612 | $6,612,151 | 71,612 | $2,631,739 |
| 2024-03 | 0 | $0 | 59,965 | $5,338,471 | 59,965 | $2,203,713 |
| 2024-02 | 0 | $0 | 132,384 | $11,412,339 | 135,182 | $5,127,080 |
| 2024-01 | 0 | $0 | 39,350 | $2,905,120 | 39,350 | $1,446,112 |
| 2023-12 | 0 | $0 | 71,018 | $5,288,758 | 71,018 | $2,920,060 |
| 2023-11 | 0 | $0 | 44,010 | $2,930,171 | 44,010 | $1,691,210 |
| 2023-10 | 0 | $0 | 80,765 | $5,578,661 | 80,765 | $3,615,883 |
| 2023-09 | 0 | $0 | 56,010 | $4,222,416 | 56,010 | $2,323,519 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-25 | Chopra Daveen (CVP, TMTT) | Sale | 2,500 | 81.95 | 204,865 |
| 2025-08-18 | Wood Larry L (Global President TAVR & Surg) | Sale | 8,950 | 78.06 | 698,681 |
| 2025-08-18 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 8,950 | 59.26 | 530,350 |
| 2025-07-28 | Lippis Daniel J. (CVP, JAPAC) | Sale | 4,114 | 79.46 | 326,902 |
| 2025-06-16 | Wood Larry L (Global President TAVR & Surg) | Sale | 8,950 | 75.23 | 673,272 |
| 2025-06-16 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 8,950 | 59.26 | 530,350 |
| 2025-06-03 | Zovighian Bernard J (CEO) | Sale | 967 | 77.32 | 74,771 |
| 2025-06-02 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 2,570 | 77.40 | 198,910 |
| 2025-05-30 | Zovighian Bernard J (CEO) | Sale | 16,099 | 77.21 | 1,243,068 |
| 2025-05-22 | Chopra Daveen (CVP, TMTT) | Sale | 1,500 | 75.08 | 112,612 |
| 2025-05-09 | Lippis Daniel J. (CVP, JAPAC) | Sale | 330 | 74.42 | 24,559 |
| 2025-05-09 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 330 | 45.28 | 14,941 |
| 2025-05-09 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 11,250 | 74.40 | 837,033 |
| 2025-05-09 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 11,250 | 45.28 | 509,366 |
| 2025-05-07 | Markowitz Wayne (GM & SVP, Surgical) | Sale | 268 | 75.08 | 20,120 |
| 2025-05-05 | Zovighian Bernard J (CEO) | Sale | 5,980 | 74.91 | 447,979 |
| 2025-05-05 | Zovighian Bernard J (CEO) | Option Ex | 7,462 | 45.28 | 337,856 |
| 2025-04-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 9,500 | 69.81 | 663,195 |
| 2025-04-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 9,500 | 45.28 | 430,131 |
| 2025-04-08 | Lippis Daniel J. (CVP, JAPAC) | Sale | 300 | 70.61 | 21,183 |
| 2025-04-08 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 300 | 45.28 | 13,583 |
| 2025-03-26 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 11,250 | 70.87 | 797,265 |
| 2025-03-26 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 11,250 | 45.28 | 509,366 |
| 2025-03-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 9,500 | 67.96 | 645,619 |
| 2025-03-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 9,500 | 45.28 | 430,131 |
| 2025-03-10 | Lippis Daniel J. (CVP, JAPAC) | Sale | 400 | 69.48 | 27,792 |
| 2025-03-10 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 400 | 45.28 | 18,110 |
| 2025-03-10 | Zovighian Bernard J (CEO) | Sale | 6,164 | 69.51 | 428,447 |
| 2025-03-10 | Zovighian Bernard J (CEO) | Option Ex | 7,463 | 45.28 | 337,902 |
| 2025-02-28 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 11,250 | 70.95 | 798,176 |
| 2025-02-28 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 11,250 | 45.28 | 509,366 |
| 2025-02-14 | Loranger Steven R (Director) | Sale | 5,739 | 76.42 | 438,574 |
| 2025-02-14 | Loranger Steven R (Director) | Option Ex | 5,739 | 45.32 | 260,074 |
| 2025-02-13 | Lippis Daniel J. (CVP, JAPAC) | Sale | 500 | 76.34 | 38,170 |
| 2025-02-13 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 500 | 45.28 | 22,638 |
| 2025-02-13 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 11,250 | 75.76 | 852,277 |
| 2025-02-13 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 11,250 | 45.28 | 509,366 |
| 2025-02-13 | Stone Heisz Leslie (Director) | Sale | 5,739 | 75.86 | 435,372 |
| 2025-02-13 | Stone Heisz Leslie (Director) | Option Ex | 5,739 | 45.32 | 260,074 |
| 2025-02-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,500 | 76.00 | 494,000 |
| 2025-02-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,500 | 45.28 | 294,300 |
| 2025-01-16 | Lippis Daniel J. (CVP, JAPAC) | Sale | 500 | 68.76 | 34,382 |
| 2025-01-16 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 500 | 45.28 | 22,638 |
| 2025-01-16 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 68.75 | 343,735 |
| 2025-01-16 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 45.28 | 226,385 |
| 2024-12-16 | Lippis Daniel J. (CVP, JAPAC) | Sale | 2,500 | 74.08 | 185,195 |
| 2024-12-16 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 2,500 | 45.28 | 113,192 |
| 2024-12-06 | Markowitz Wayne (GM & SVP, Surgical) | Sale | 583 | 73.27 | 42,716 |
| 2024-12-06 | Chopra Daveen (CVP, TMTT) | Sale | 1,750 | 73.27 | 128,222 |
| 2024-11-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 65.57 | 327,845 |
| 2024-11-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 45.28 | 226,385 |
| 2024-11-05 | Wood Larry L (Global President TAVR & Surg) | Sale | 25,000 | 65.92 | 1,647,875 |
| 2024-10-15 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 69.51 | 347,535 |
| 2024-10-15 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 45.28 | 226,385 |
| 2024-09-11 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 66.77 | 333,825 |
| 2024-09-11 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 45.28 | 226,385 |
| 2024-08-20 | Chopra Daveen (CVP, TMTT) | Sale | 1,250 | 69.95 | 87,437 |
| 2024-08-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 66.08 | 330,420 |
| 2024-08-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 45.28 | 226,385 |
| 2024-07-11 | Lippis Daniel J. (CVP, JAPAC) | Sale | 500 | 94.18 | 47,090 |
| 2024-07-11 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 500 | 45.28 | 22,638 |
| 2024-07-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 93.30 | 466,475 |
| 2024-07-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 45.28 | 226,385 |
| 2024-06-20 | Lippis Daniel J. (CVP, JAPAC) | Sale | 535 | 90.00 | 48,150 |
| 2024-06-20 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 535 | 45.28 | 24,223 |
| 2024-06-20 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 5,625 | 87.79 | 493,818 |
| 2024-06-20 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 5,625 | 45.28 | 254,683 |
| 2024-06-12 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 87.54 | 437,695 |
| 2024-06-12 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 45.28 | 226,385 |
| 2024-05-30 | Zovighian Bernard J (CEO) | Sale | 8,617 | 87.68 | 755,538 |
| 2024-05-21 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 5,625 | 90.45 | 508,803 |
| 2024-05-21 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 5,625 | 45.28 | 254,683 |
| 2024-05-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 87.81 | 439,040 |
| 2024-05-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 45.28 | 226,385 |
| 2024-05-07 | Lippis Daniel J. (CVP, JAPAC) | Sale | 1,714 | 85.60 | 146,718 |
| 2024-05-07 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 1,714 | 36.75 | 62,988 |
| 2024-05-06 | Zovighian Bernard J (CEO) | Buy | 580 | 85.74 | 49,730 |
| 2024-05-04 | Chopra Daveen (CVP, TMTT) | Option Ex | 4,713 | .00 | 0 |
| 2024-05-04 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Option Ex | 4,157 | .00 | 0 |
| 2024-05-04 | Zovighian Bernard J (CEO) | Option Ex | 6,265 | .00 | 0 |
| 2024-05-04 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,465 | .00 | 0 |
| 2024-05-04 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 6,675 | .00 | 0 |
| 2024-05-04 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 5,796 | .00 | 0 |
| 2024-05-04 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,855 | .00 | 0 |
| 2024-05-02 | Mussallem Michael A (Director) | Sale | 29,350 | 84.81 | 2,489,026 |
| 2024-05-02 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2024-05-01 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Sale | 14,400 | 84.47 | 1,216,353 |
| 2024-05-01 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Option Ex | 14,400 | 36.75 | 529,200 |
| 2024-04-30 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 7,250 | 86.07 | 624,007 |
| 2024-04-30 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,250 | 36.75 | 266,437 |
| 2024-04-09 | Lippis Daniel J. (CVP, JAPAC) | Sale | 857 | 92.34 | 79,135 |
| 2024-04-09 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 857 | 36.75 | 31,494 |
| 2024-04-08 | Lemercier Jean-luc M (CVP, EMEACLA) | Sale | 14,400 | 92.49 | 1,331,798 |
| 2024-04-08 | Lemercier Jean-luc M (CVP, EMEACLA) | Option Ex | 14,400 | 36.75 | 529,200 |
| 2024-04-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 12,500 | 92.49 | 1,156,175 |
| 2024-04-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 12,500 | 36.75 | 459,375 |
| 2024-04-04 | Mussallem Michael A (Director) | Sale | 29,350 | 93.04 | 2,730,665 |
| 2024-04-04 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2024-04-01 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 7,255 | 95.16 | 690,371 |
| 2024-04-01 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,255 | 36.75 | 266,621 |
| 2024-03-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 14,500 | 91.01 | 1,319,703 |
| 2024-03-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 14,500 | 36.75 | 532,875 |
| 2024-03-11 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Sale | 14,400 | 91.68 | 1,320,148 |
| 2024-03-11 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Option Ex | 14,400 | 36.75 | 529,200 |
| 2024-03-07 | Lippis Daniel J. (CVP, JAPAC) | Sale | 1,715 | 90.98 | 156,030 |
| 2024-03-07 | Lippis Daniel J. (CVP, JAPAC) | Option Ex | 1,715 | 36.75 | 63,026 |
| 2024-03-04 | Mussallem Michael A (Director) | Sale | 29,350 | 86.63 | 2,542,590 |
| 2024-03-04 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2024-02-29 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 7,255 | 85.59 | 620,926 |
| 2024-02-29 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,255 | 36.75 | 266,621 |
| 2024-02-23 | Gallahue Kieran (Director) | Sale | 3,058 | 87.61 | 267,911 |
| 2024-02-23 | Gallahue Kieran (Director) | Option Ex | 7,056 | 36.86 | 260,105 |
| 2024-02-21 | Chopra Daveen (CVP, TMTT) | Sale | 8,200 | 86.71 | 711,030 |
| 2024-02-21 | Chopra Daveen (CVP, TMTT) | Option Ex | 7,000 | 59.26 | 414,799 |
| 2024-02-15 | Szyman Catherine M. (CVP, Critical Care) | Sale | 27,000 | 85.62 | 2,311,659 |
| 2024-02-15 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 27,000 | 36.75 | 992,250 |
| 2024-02-13 | Szyman Catherine M. (CVP, Critical Care) | Sale | 20,000 | 86.46 | 1,729,199 |
| 2024-02-13 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 20,000 | 36.75 | 735,000 |
| 2024-02-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 11,000 | 86.08 | 946,858 |
| 2024-02-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 11,000 | 36.75 | 404,250 |
| 2024-02-12 | Sellers Robert W.a. (SVP, Corporate Controller) | Sale | 12,210 | 87.00 | 1,062,270 |
| 2024-02-12 | Sellers Robert W.a. (SVP, Corporate Controller) | Option Ex | 12,210 | 36.75 | 448,717 |
| 2024-02-08 | Stone Heisz Leslie (Director) | Sale | 7,056 | 86.45 | 609,991 |
| 2024-02-08 | Stone Heisz Leslie (Director) | Option Ex | 7,056 | 36.86 | 260,105 |
| 2024-02-05 | Mussallem Michael A (Director) | Sale | 29,350 | 88.06 | 2,584,502 |
| 2024-02-05 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2024-02-01 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 7,255 | 78.29 | 567,993 |
| 2024-02-01 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,255 | 36.75 | 266,621 |
| 2024-01-12 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 10,000 | 75.67 | 756,700 |
| 2024-01-12 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 10,000 | 36.75 | 367,500 |
| 2024-01-05 | Mussallem Michael A (Director) | Sale | 29,350 | 73.20 | 2,148,420 |
| 2024-01-05 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2023-12-29 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 14,510 | 76.55 | 1,110,798 |
| 2023-12-29 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 14,510 | 36.75 | 533,242 |
| 2023-12-15 | Chopra Daveen (CVP, TMTT) | Sale | 7,000 | 78.25 | 547,722 |
| 2023-12-15 | Chopra Daveen (CVP, TMTT) | Option Ex | 7,000 | 59.26 | 414,799 |
| 2023-12-13 | Wood Larry L (Global President TAVR & Surg) | Sale | 8,658 | 71.86 | 622,163 |
| 2023-12-13 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 8,658 | 45.28 | 392,008 |
| 2023-12-13 | Mussallem Michael A (Director) | Sale | 29,350 | 74.56 | 2,188,189 |
| 2023-12-13 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2023-12-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 8,000 | 71.86 | 574,880 |
| 2023-12-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 8,000 | 36.75 | 294,000 |
| 2023-12-06 | Chopra Daveen (CVP, TMTT) | Sale | 3,500 | 70.00 | 245,006 |
| 2023-12-06 | Chopra Daveen (CVP, TMTT) | Option Ex | 3,500 | 59.26 | 207,399 |
| 2023-11-13 | Wood Larry L (Global President TAVR & Surg) | Sale | 8,660 | 65.51 | 567,316 |
| 2023-11-13 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 8,660 | 45.28 | 392,098 |
| 2023-11-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,000 | 65.19 | 391,122 |
| 2023-11-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,000 | 36.75 | 220,500 |
| 2023-11-03 | Mussallem Michael A (Director) | Sale | 29,350 | 67.18 | 1,971,733 |
| 2023-11-03 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
Insider trading activities including stock purchases, stock sales, and option exercises of EW listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Edwards Lifesciences Corp (symbol EW, CIK number 1099800) see the Securities and Exchange Commission (SEC) website.